Antibiotic resistance: Can we beat the bugs?

Drug Discovery Today

Volumn 6, Issue 14, 2001, Pages 714-715

  Drlica, Karl ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DRUG BLOOD LEVEL; DRUG DOSE; GENETIC SELECTION; HOST RESISTANCE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; PENICILLIN RESISTANCE; SHIGELLA DYSENTERIAE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE;

EID: 0035397161     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01882-7     Document Type: Note

References (8)

1. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collective surveillance study
2. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistance to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid
3. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
4. Pharmacodyamics of levofloxacin: a new paradigm for early clinical trials
5. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance
6. Selection of antibiotic resistance: allelic diversity among fluoroquinolone-resistant mutations
7. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus
8. New quinolones and the impact on resistance